Russell Hill appointed CEO of Pharmacy and Compounding (AU/NZ)

Icon Writers / 03 Jul, 2025

Icon Group is proud to announce the formal appointment of Russell Hill as Chief Executive Officer of our Pharmacy and Compounding division across Australia and New Zealand.

Following David Slade’s transition from his role as Global Director of Pharmacy and Compounding last year, Russell has led the division as Acting CEO with a clear focus on strategic alignment, patient-centred care, and operational excellence. His leadership has been instrumental in driving sustainable growth and innovation in a complex and evolving healthcare landscape.

Throughout his tenure, Russell has worked closely with his leadership team to integrate digital transformation initiatives, enhance commercial excellence, and ensure the delivery of high-quality, patient-first services. His appointment marks a significant milestone in the continued evolution of Icon Group’s pharmacy and compounding capabilities.

“Russell’s appointment is a testament to his unwavering commitment to our mission and the impact of his leadership across both pharmacy and compounding,” said Icon Group CEO Mark Middleton.

“His strategic vision, collaborative spirit, and deep understanding of our business will continue to shape the future of these critical services. “I’m thrilled to see him take on this role and lead our teams into the next phase of growth.”

This appointment comes at a significant moment in our history, as we celebrate 60 years of Slade – a legacy built on innovation, integrity, and a deep commitment to patient care.

“Slade has a proud 60-year history of delivering trusted, high-quality care to patients and communities,” said Russell.

“It’s humbling to step into this role knowing the incredible history that has shaped our pharmacy and compounding services, and the leaders and teams who have contributed to its success. I’m proud to contribute to Slade’s legacy, working together to bring more care, to more people, closer to home.”

Please join us in congratulating Russell on his appointment.

Learn more about Russell.

Learn more about Slade 60 Years.

View all News

Search

Contact us